Emerson Software Selected by Bristol-Myers Squibb for New Biopharmaceutical Facility
Monday, February 16, 2009
Global biopharmaceutical company Bristol-Myers Squibb (BMS) has selected Emerson Process Management to fully automate its new facility in Devens, MA. Emerson will apply its PlantWeb digital plant architecture including the new Syncade Smart Operations Management suite, DeltaV digital automation system and network of intelligent digital field devices.
BMS is investing $750 million in the construction of the new brownfield plant. This Large-Scale Cell Culture manufacturing facility will produce commercial biopharmaceuticals that support the company's mission to extend and enhance human life. The flexible facility will have 120,000 liters of bioreactor capacity and is designed for campaigned, multi-product production. The groundbreaking for this facility was in March 2007, with plans to be commercially operational in 2011. More...
|
|
Email to a Friend